Extracts of Pumpkin (Cucurbita pepo L.) Seeds Suppress Stimulated Peripheral Blood Mononuclear Cells in vitro
Christiana Winkler1, Barbara Wirleitner1, Katharaina Schroecksnadel1, Harald Schennach2 & Dietmar Fuchs3 Show affiliations
- Innsbruck Medical University, Austria
- University Hospital, Austria
- Ludwig Boltzmann Institute of AIDS-Research, Austria
American Journal of Immunology, Volume 1, Issue 1, pp. 6–11 · doi.org/10.3844/ajisp.2005.6.11
Abstract
In the traditional medicine in North America and Mexico, pumpkin seeds have been used as an anthelmintic agent and for supportive treatment in functional disorders of the bladder. Also anti-inflammatory and cardioprotective activity of pumpkin seeds is discussed. Three different extracts of pumpkin seeds were prepared and effects were investigated in unstimulated human peripheral blood mononuclear cells and in cells stimulated with the mitogens phytohaemagglutinin and concanavalin A in vitro. Tryptophan degradation and neopterin concentrations were measured in the supernatants allowing to detect biochemical changes induced by cytokine interferon-γ. Extracts of pumpkin seeds suppressed mitogen-induced neopterin production and tryptophan degradation in a dose-dependent way. Data demonstrate capacity of pumpkin extracts to modulate immunobiochemical pathways induced by interferon- γ. Findings imply an immunoregulatory potential of compounds contained in pumpkin seeds.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2005 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Winkler, C., Wirleitner, B., Schroecksnadel, K., Schennach, H. & Fuchs, D. (2005). Extracts of Pumpkin (Cucurbita pepo L.) Seeds Suppress Stimulated Peripheral Blood Mononuclear Cells in vitro. American Journal of Immunology, 1(1), 6–11. https://doi.org/10.3844/ajisp.2005.6.11
- Licence
- © Science Publications
- Issue
- Volume 1, Issue 1
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
